No valuation score is currently available for Nervgen Pharma Ord Shs. The Biotechnology & Medical Research industry's average is 7.87. Its current P/E ratio is -5.18, which is -19.16% below the recent high of -4.19 and -71.96% above the recent low of -8.90.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.